Betafron subcutaneous injection 9.6 million international units, manufactured by Bayer Pharmaceutical, contains Interferon beta-1b (genetical recombination) and is an injectable drug supplied as 9.6 million international units x 1 bottle with dissolving solution (YJ code: 6399416D1033). It is used for the treatment of relapsing forms of multiple sclerosis.
Betafron subcutaneous injection 9.6 million international units
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).